IN THE MATTER OF Mark Andrew Reynolds, Robert John Oliver, and Lawrence Bradley Chang - Set Date



    VANCOUVER, Jan. 19 /CNW/ - Notice is hereby given that an appearance will
be held before a Hearing Panel of the Investment Industry Regulatory
Organization of Canada (IIROC), on January 29, 2009, at Reportex Agencies
Ltd., located at 925 West Georgia Street, Suite 1010, Vancouver, British
Columbia, at 10:00 a.m. or as soon thereafter as the appearance can be held,
to set the date for a hearing in the matter of Mark Andrew Reynolds, Robert
John Oliver, and Lawrence Bradley Chang (the "Respondents").
    The proposed hearing concerns matters for which the Respondents may be
disciplined as Regulated Persons of IIROC, pursuant to Part 10 of IIROC Dealer
Member Rule 20.

    The hearing concerns allegations that:

    
    (a)   between approximately January 1, 2004, and July 9, 2004, while Mark
          Andrew Reynolds was a Registered Representative at Research Capital
          Corporation, he failed to properly perform his role as a gatekeeper
          to the capital markets and acted contrary to IDA By-law 29.1 and/or
          IDA Regulation 1300.1(a) by accepting order to buy and sell shares
          of Aberdene Mines Limited in client accounts without making
          reasonable or diligent inquiries to reasonably:

          (i)   inform himself of the essential facts relative to his clients
                and their orders;  and/or

          (ii)  assure himself the transactions were not being effected by
                his clients for improper purposes

          in circumstances which necessitated such inquiries;

    (b)   between approximately January 1, 2004, and July 9, 2004, while
          Robert John Oliver was a Registered Representative at Wolverton
          Securities ltd., he failed to properly perform his role as a
          gatekeeper to the capital markets and acted contrary to IDA By-law
          29.1 and/or IDA Regulation 1300.1(a) by accepting orders to buy and
          sell shares of Aberdene Mines Limited in client accounts without
          making reasonable or diligent inquiries to reasonably:

          (i)   inform himself of the essential facts relative to his clients
                and their orders;  and/or

          (ii)  assure himself the transactions were not being effected by
                his clients for improper purposes

          in circumstances which necessitated such inquiries;

    (c)   between approximately January 1, 2004, and July 9, 2004, while
          Lawrence Bradley Chang was a Registered Representative at Wolverton
          Securities Ltd., he failed to properly perform his role as a
          gatekeeper to the capital markets and acted contrary to IDA By-law
          29.1 and/or IDA Regulation 1300.1(a), (o), and (p) by accepting
          orders to buy and sell shares of Aberdene Mines Limited in client
          accounts without making reasonable or diligent inquiries to
          reasonably:

          (i)   inform himself of the essential facts relative to his clients
                and their orders; and/or

          (ii)  assure himself the transactions were not being effected by
                his clients for improper purposes; and/or

          (iii) assure himself that the transactions were suitable for his
                clients

          in circumstances which necessitated such inquiries;

    (d)   on or about October 18, 2002, while he was a Registered
          Representative (RR) at Wolverton Securities Ltd., Lawrence Bradley
          Chang acted contrary to IDA By-law 29.1 by allowing a U.S. resident
          client to change his address and use a Canadian address when he
          knew, or ought to have known that the client was resident in the
          U.S. and was only using the Canadian address in order to avoid a
          direction made by Wolverton to close accounts for clients residing
          in the U.S. where neither the RR nor the firm were registered.
    

    IIROC formally initiated the investigation into the Respondents' conduct
on January 27, 2005. The alleged violations occurred when Mark Andrew Reynolds
was a Registered Representative with the No.564-1055 Dunsmuir Street Branch of
Research Capital Corporation, and Robert John Oliver and Lawrence Bradley
Chang were Registered Representatives with the (number sing)1077-777 Dunsmuir
Street Branch of Wolverton Securities Ltd. Mark Andrew Reynolds and Robert
John Oliver are no longer registered in any capacity with an IIROC Dealer
Member. Lawrence Bradley Chang is currently a Registered Representative at the
#2200-609 Granville Street Branch of Canaccord Capital Corporation, an
IIROC-regulated firm.
    The hearing is open to the public, unless the Hearing Panel orders
otherwise. The Notice of Hearing is available at www.iiroc.ca.

    IIROC is the national self-regulatory organization which oversees all
investment dealers and trading activity on debt and equity marketplaces in
Canada. Created in 2008 through the consolidation of the Investment Dealers
Association of Canada and Market Regulation Services Inc., IIROC sets high
quality regulatory and investment industry standards, protects investors and
strengthens market integrity while maintaining efficient and competitive
capital markets. IIROC carries out its regulatory responsibilities through
setting and enforcing rules regarding the proficiency, business and financial
conduct of dealer firms and their registered employees and through setting and
enforcing market integrity rules regarding trading activity on Canadian equity
marketplaces.





For further information:

For further information: Warren Funt, Vice-President, Western Canada 
(604) 331-4750, wfunt@iiroc.ca; Jeff Kehoe, Director, Enforcement, (416)
943-6996, jkehoe@iiroc.ca


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890